Portland-based ImmuCell reports big revenue boost for 3rd quarter

Portland biotech firm ImmuCell Corp. on Monday reported a significant revenue increase for the third quarter, with sales up 38 percent from a year earlier to $3 million.

The company, which develops and manufactures bovine health products for the dairy and beef industries, said the revenue boost was the result of eliminating a production bottleneck that had restricted sales in 2018 despite increased customer demand.

ImmuCell reported a net loss of $503,000, or 7 cents per share, for the third quarter as it continued to absorb the costs of a $20 million manufacturing facility completed in late 2017 for a new product called Re-Tain that must receive regulatory approval before sales can commence. Read more

Related Posts

UMaine professor McGill receives top German research award

ORONO — University of Maine ecology professor Brian McGill was awarded the Humboldt Research Award, one of the most prestigious scientific...

20 July 2023

Four Maine workforce programs could get $6.5M in fed funding

Four workforce training programs in Maine could receive nearly $6.5 million in federal funding through the markup of the fiscal year 2024 financial...

18 July 2023

Music as medicine: FDA approves stroke damage therapy from Portland startup

Doctors may soon start writing an unconventional prescription to help stroke survivors regain their ability to walk: music. MedRhythms, a Portland...

14 July 2023